Inflammatory bowel disease

Letter
Year 2025 / Volume 117 / Number 6
359-360
DOI: 10.17235/reed.2024.10822/2024
Marta Fernández Carrasco, Alejandro Rodríguez Mateu, Olga Sánchez García,
The differential diagnosis between Crohn’s disease (CD) and intestinal tuberculosis (ITB) continues to pose a diagnostic challenge, as clinical presentation can be indistinguishable, as well as findings...
Reader rating:
Letter
Year 2025 / Volume 117 / Number 6
342-343
DOI: 10.17235/reed.2024.10405/2024
Kazuhiro Furukawa, Masahiro Oda, Osamu Watanabe, Masanao Nakamura, Takeshi Yamamura, Keiko Maeda, Kensaku Mori, Hiroki Kawashima,
Since even subtle mucosal changes may be depicted using virtual endoscopy created by the three-dimensional reconstruction of MDCT images, we developed a novel diagnostic imaging system that integrates...
Reader rating:
Original
Year 2025 / Volume 117 / Number 5
241-248
DOI: 10.17235/reed.2024.10731/2024
Rubén Pampín Sánchez, Alba Gonzalo González, Santiago Fuertes Camporro, Ane Goenaga Ansola, Andrea Fórneas Sangil, Sonia Tembrás Martínez, Pilar Varela Trastoy, Cristina Martínez-Múgica Barbosa,
Background and purpose: ustekinumab is a monoclonal antibody approved for the treatment of moderate to severe Crohn’s disease (CD) and ulcerative colitis (UC). In spite of being an effective treatment,...
Reader rating:
Letter
Year 2025 / Volume 117 / Number 5
289-290
DOI: 10.17235/reed.2024.10378/2024
Akira Hokama,
I read with great interest the letter by Calderón et al., who clearly described effectiveness of hyperbaric oxygen therapy (HBOT) for refractory ischemic ulcer at the ileorectal anastomosis in Crohn’s...
Reader rating:
Letter
Year 2025 / Volume 117 / Number 5
286-287
DOI: 10.17235/reed.2024.10512/2024
Alex Fabián Arenas Aravena, Diego Ruedi, Matías Sanhueza, Sebastián Ibáñez, Gonzalo Carrasco-Avino, Patricio Ibáñez,
We show an unusual case of ulcerative colitis and sarcoidosis. This case has detailed images of skin lesions, biopsies and PET-CT results. There is limited evidence regarding the association of inflammatory...
Reader rating:
Original
Year 2025 / Volume 117 / Number 4
205-212
DOI: 10.17235/reed.2024.10521/2024
Carles Iniesta-Navalón, Manuel Ríos-Saorín, Lorena Rentero-Redondo, Isabel Nicolás-de Prado, Rosa Gómez-Espín, Elena Urbieta-Sanz,
Background: understanding the relationship between ustekinumab (UST) exposure and clinical outcomes in inflammatory bowel disease (IBD) induction is crucial. However, evidence remains limited, highlighting...
Reader rating:
Letter
Year 2025 / Volume 117 / Number 4
230-231
DOI: 10.17235/reed.2024.10348/2024
Yi Lu, Hailing Liu, Xiaoying Lou, Jiachen Sun,
Patients with ulcerative colitis are at increased risk for colorectal neoplasia compared to the general population. The risk factors include family history of colorectal cancer, wide extent of colitis,...
Reader rating:
Review
Year 2025 / Volume 117 / Number 3
129-135
DOI: 10.17235/reed.2023.9444/2022
Rui Li, Lei Yang,
In recent years, more and more drugs have been used in the treatment of ulcerative colitis, but the efficacy of monotherapy is limited, especially for patients with refractory moderate to severe ulcerative...
Reader rating:
Letter
Year 2025 / Volume 117 / Number 2
119-120
DOI: 10.17235/reed.2024.10214/2023
Rodrigo Meza, Teresa Peralta, Diego Ruedi, Alex Arenas Aravena,
We report the case of a 34-year-old female with Crohn’s disease (CD), was treated with infliximab and ileocecal resection after failure to anti-TNF. She started adalimumab for postoperative recurrence...
Reader rating:
Letter
Year 2025 / Volume 117 / Number 2
113-114
DOI: 10.17235/reed.2024.10290/2024
Eugenia Navarro Moreno, Marta Lázaro Sáez, José Luis Vega Sáenz,
Both psoriasis and inflammatory bowel disease (IBD) are immunomediated diseases. Some of their therapeutic tools are monoclonal antibodies. Ixekizumab is an interleukin-17 (IL-17) inhibitor approved for...
Reader rating:

Page 1 of 18
1
2
3
4
5
6
7
>>
Submission and tracking of manuscripts
Instructions to authors

Submission and tracking

Asociación Española de Ecografía Digestiva Sociedad Española de Endoscopia Digestiva Sociedad Española de Patología Digestiva
The Spanish Journal of Gastroenterology is the official organ of the Sociedad Española de Patología Digestiva, the Sociedad Española de Endoscopia Digestiva and the Asociación Española de Ecografía Digestiva
Cookie policy Privacy Policy Legal Notice © Copyright 2025 y Creative Commons. The Spanish Journal of Gastroenterology